We further defined this population in the AD group with regard to the expression of cell surface inhibitory markers (Tim3, PD1, CD40L and CTLA-4) and found that CTLA-4 was significantly co-expressed by CD4+HLA-G+ T cells in patients with AD compared with HCs (figure 2A). The gene discussed is CD40LG; the disease is Alzheimer disease.